Corrigendum to ‘Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation’ [Biomater. Adv. 145 (2023) 213266] (Biomaterials Advances (2023) 145, (S277295082200543X), (10.1016/j.bioadv.2022.213266))
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jamshaid, Humzah | - |
dc.contributor.author | ud Din, Fakhar | - |
dc.contributor.author | Nousheen, Kainat | - |
dc.contributor.author | Khan, Saif Ullah | - |
dc.contributor.author | Fatima, Anam | - |
dc.contributor.author | Khan, Salman | - |
dc.contributor.author | Choi, Han Gon | - |
dc.contributor.author | Khan, Gul Majid | - |
dc.date.accessioned | 2023-05-03T09:32:19Z | - |
dc.date.available | 2023-05-03T09:32:19Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.issn | 2772-9508 | - |
dc.identifier.issn | 2772-9508 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/112522 | - |
dc.description.abstract | In Fig. 6B, the micrographs of invitro antileishmanial assay against intramacrophage resident L. major amastigotes are shown. The previously presented images were mistakenly added as those were not the part of the study of this research, hence replaced in the revised Fig. 6. However, the text and all the related data of these figures (in the published article) are correct and do not require any change. © 2023 Elsevier B.V. | - |
dc.format.extent | 2 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier Ltd | - |
dc.title | Corrigendum to ‘Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation’ [Biomater. Adv. 145 (2023) 213266] (Biomaterials Advances (2023) 145, (S277295082200543X), (10.1016/j.bioadv.2022.213266)) | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.bioadv.2023.213350 | - |
dc.identifier.scopusid | 2-s2.0-85149380211 | - |
dc.identifier.wosid | 001004576000001 | - |
dc.identifier.bibliographicCitation | Biomaterials Advances, v.148, pp 1 - 2 | - |
dc.citation.title | Biomaterials Advances | - |
dc.citation.volume | 148 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 2 | - |
dc.type.docType | Correction | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | drug comparison | - |
dc.subject.keywordPlus | erratum | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | nonhuman | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S2772950823000730?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.